Target intelligence / Profile preview

Renal ion transport pathways

Molecular classification
Transporter, Ion channel, Enzyme
01

Overview

Renal ion transport pathways represent the collective mechanisms and protein complexes responsible for the selective reabsorption and secretion of electrolytes and water across the nephron's epithelial cells. These pathways are fundamental to maintaining systemic homeostasis, including the regulation of blood pressure, extracellular fluid volume, and acid-base balance (StatPearls, NBK541081). Key molecular components include the sodium-glucose cotransporter 2 (SGLT2) in the proximal tubule, the Na-K-2Cl cotransporter (NKCC2) in the thick ascending limb, and the epithelial sodium channel (ENaC) in the distal nephron (NIH, PMC4862388). Pharmacological agents such as loop diuretics, thiazides, and SGLT2 inhibitors target these specific transporters to treat conditions like hypertension, heart failure, and chronic kidney disease (PubMed, 29025460). Dysregulation of these pathways, whether through genetic mutations or acquired disease, can lead to severe electrolyte imbalances and metabolic disorders. Consequently, these pathways are among the most clinically significant therapeutic targets in cardiovascular and renal medicine.

Other names
Renal electrolyte transportKidney ion transportRenal tubular transportRenal solute transport
02

Mechanism of action

Inhibition of specific renal transporters or ion channels (such as NKCC2, NCC, ENaC, or SGLT2) to decrease the reabsorption of sodium and other solutes from the tubular lumen, thereby promoting natriuresis and diuresis.

03

Biological functions

OsmoregulationAcid-base balanceElectrolyte homeostasisBlood pressure regulationFluid volume regulation
04

Disease associations

HypertensionHeart failureEdemaChronic kidney diseaseNephrolithiasisBartter syndromeGitelman syndromeLiddle syndrome
05

Safety considerations

HypokalemiaHyponatremiaHypovolemiaMetabolic alkalosisMetabolic acidosisAcute kidney injuryHyperkalemia
06

Interacting drugs

Furosemide

7 more in the full profile.

07

Biomarkers

Serum potassiumSerum sodiumUrinary sodium excretionBlood pressureEstimated glomerular filtration rate (eGFR)Plasma renin activity

Beyond the preview

Go deeper on Renal ion transport pathways.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal ion transport pathways.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call